Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

2.
4.

Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone.

Nakai S, Hirose T, Uwahodo Y, Imaoka T, Okazaki H, Miwa T, Nakai M, Yamada S, Dunn B, Burris KD, Molinoff PB, Tottori K, Altar CA, Kikuchi T.

Eur J Pharmacol. 2003 Jul 4;472(1-2):89-97.

PMID:
12860477
5.

PT-141: a melanocortin agonist for the treatment of sexual dysfunction.

Molinoff PB, Shadiack AM, Earle D, Diamond LE, Quon CY.

Ann N Y Acad Sci. 2003 Jun;994:96-102.

PMID:
12851303
6.

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.

Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB.

J Pharmacol Exp Ther. 2002 Jul;302(1):381-9.

PMID:
12065741
7.

Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels.

Gribkoff VK, Starrett JE Jr, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K, Johnson G, Krishnan BS, Kinney GG, Lombardo LA, Meanwell NA, Molinoff PB, Myers RA, Moon SL, Ortiz A, Pajor L, Pieschl RL, Post-Munson DJ, Signor LJ, Srinivas N, Taber MT, Thalody G, Trojnacki JT, Wiener H, Yeleswaram K, Yeola SW.

Nat Med. 2001 Apr;7(4):471-7.

PMID:
11283675
8.

Characterization of 5-HT- and ionomycin-stimulated changes in levels of intracellular calcium and PI hydrolysis in P11 cells.

Wohlpart KL, Molinoff PB.

Ann N Y Acad Sci. 1998 Dec 15;861:240-1. No abstract available.

PMID:
9928265
9.

Regulation of levels of 5-HT2A receptor mRNA.

Wohlpart KL, Molinoff PB.

Ann N Y Acad Sci. 1998 Dec 15;861:128-35. Review.

PMID:
9928249
10.

Regulation of D2 and D3 receptors in transfected cells by agonists and antagonists.

Burris KD, Fausing SM, Molinoff PB.

Adv Pharmacol. 1998;42:443-6. No abstract available.

PMID:
9327934
12.
13.

Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugiperda insect cells.

Boundy VA, Lu L, Molinoff PB.

J Pharmacol Exp Ther. 1996 Feb;276(2):784-94.

PMID:
8632351
14.

Regulation of 5-HT2A receptor mRNA in P11 cells.

Ferry RC, Molinoff PB.

Behav Brain Res. 1996;73(1-2):187-91. Review.

PMID:
8788500
15.
16.

Expression of the human 5-hydroxytryptamine1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits.

Butkerait P, Zheng Y, Hallak H, Graham TE, Miller HA, Burris KD, Molinoff PB, Manning DR.

J Biol Chem. 1995 Aug 4;270(31):18691-9.

17.

Lack of discrimination by agonists for D2 and D3 dopamine receptors.

Burris KD, Pacheco MA, Filtz TM, Kung MP, Kung HF, Molinoff PB.

Neuropsychopharmacology. 1995 Jul;12(4):335-45.

18.

Expression of mRNAs encoding subunits of the NMDA receptor in developing rat brain.

Zhong J, Carrozza DP, Williams K, Pritchett DB, Molinoff PB.

J Neurochem. 1995 Feb;64(2):531-9.

PMID:
7830045
19.
20.

Mechanisms of up-regulation of D2L dopamine receptors by agonists and antagonists in transfected HEK-293 cells.

Filtz TM, Guan W, Artymyshyn RP, Facheco M, Ford C, Molinoff PB.

J Pharmacol Exp Ther. 1994 Dec;271(3):1574-82.

PMID:
7996471
21.

Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain.

Kung MP, Chumpradit S, Frederick D, Garner S, Burris KD, Molinoff PB, Kung HF.

Naunyn Schmiedebergs Arch Pharmacol. 1994 Dec;350(6):611-7.

PMID:
7708118
22.

International Union of Pharmacology nomenclature of adrenoceptors.

Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U.

Pharmacol Rev. 1994 Jun;46(2):121-36. Review. No abstract available.

PMID:
7938162
23.

Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons.

Zhong J, Russell SL, Pritchett DB, Molinoff PB, Williams K.

Mol Pharmacol. 1994 May;45(5):846-53.

PMID:
8190101
24.

Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits.

Williams K, Zappia AM, Pritchett DB, Shen YM, Molinoff PB.

Mol Pharmacol. 1994 May;45(5):803-9.

PMID:
8190097
25.

Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.

Unsworth CD, Molinoff PB.

J Pharmacol Exp Ther. 1994 Apr;269(1):246-55.

PMID:
8169832
26.

Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle.

Burris KD, Filtz TM, Chumpradit S, Kung MP, Foulon C, Hensler JG, Kung HF, Molinoff PB.

J Pharmacol Exp Ther. 1994 Feb;268(2):935-42.

PMID:
8114008
27.

Molecular pharmacology of NMDA receptors: modulatory role of NR2 subunits.

Molinoff PB, Williams K, Pritchett DB, Zhong J.

Prog Brain Res. 1994;100:39-45. Review. No abstract available.

PMID:
7938532
28.

Paradoxical regulation of dopamine receptors in transfected 293 cells.

Filtz TM, Artymyshyn RP, Guan W, Molinoff PB.

Mol Pharmacol. 1993 Aug;44(2):371-9.

PMID:
8102783
29.

Characterization of a mouse beta 1-adrenergic receptor genomic clone.

Cohen JA, Baggott LA, Romano C, Arai M, Southerling TE, Young LH, Kozak CA, Molinoff PB, Greene MI.

DNA Cell Biol. 1993 Jul-Aug;12(6):537-47.

PMID:
8392347
30.
31.

Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.

Boundy VA, Luedtke RR, Artymyshyn RP, Filtz TM, Molinoff PB.

Mol Pharmacol. 1993 May;43(5):666-76.

PMID:
8502224
32.
33.

Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro.

Williams K, Russell SL, Shen YM, Molinoff PB.

Neuron. 1993 Feb;10(2):267-78.

PMID:
8439412
34.

Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies.

Boundy VA, Luedtke RR, Gallitano AL, Smith JE, Filtz TM, Kallen RG, Molinoff PB.

J Pharmacol Exp Ther. 1993 Feb;264(2):1002-11.

PMID:
8437101
35.
36.

An antagonist/partial agonist at the polyamine recognition site of the N-methyl-D-aspartate receptor that alters the properties of the glutamate recognition site.

Williams K, Pullan LM, Romano C, Powel RJ, Salama AI, Molinoff PB.

J Pharmacol Exp Ther. 1992 Aug;262(2):539-44.

PMID:
1354252
37.

Comparison of the expression, transcription and genomic organization of D2 dopamine receptors in outbred and inbred strains of rat.

Luedtke RR, Artymyshyn RP, Monks BR, Molinoff PB.

Brain Res. 1992 Jul 3;584(1-2):45-54.

PMID:
1355393
38.

Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists.

Williams K, Dichter MA, Molinoff PB.

Mol Pharmacol. 1992 Jul;42(1):147-51.

PMID:
1353248
39.

Effects of mono-, di-, and triamines on the N-methyl-D-aspartate receptor complex: a model of the polyamine recognition site.

Romano C, Williams K, DePriest S, Seshadri R, Marshall GR, Israel M, Molinoff PB.

Mol Pharmacol. 1992 Apr;41(4):785-92.

PMID:
1533270
41.

Quantitation of isotypes of D2 receptors using solution hybridization.

Artymyshyn RP, Ivins KJ, Monks BR, Luedtke RR, Molinoff PB.

Neurochem Int. 1992 Mar;20 Suppl:189S-195S. Review.

PMID:
1365424
42.

Down-regulation of beta-adrenergic receptors by pindolol in Gs alpha-transfected S49 cyc- murine lymphoma cells.

Gonzales JM, O'Donnell JK, Stadel JM, Sweet RW, Molinoff PB.

J Neurochem. 1992 Mar;58(3):1093-1103.

PMID:
1310718
43.

Effect of N-alkylation on the affinities of analogues of spiperone for dopamine D2 and serotonin 5-HT2 receptors.

Mach RH, Jackson JR, Luedtke RR, Ivins KJ, Molinoff PB, Ehrenkaufer RL.

J Med Chem. 1992 Feb 7;35(3):423-30.

PMID:
1531364
44.

Subtypes of serotonin receptors and anxiolytic drugs: model systems for the study of 5-HT receptors.

Molinoff PB, Unsworth CD, Ferry RC, Hensler JG.

Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:531A-532A. No abstract available.

PMID:
1354062
45.

Evolving properties of beta-adrenergic receptor antagonists.

Molinoff PB.

Pharmacotherapy. 1992;12(2):144-53. Review. No abstract available.

PMID:
1349167
46.
47.

Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing.

Marzo KP, Frey MJ, Wilson JR, Liang BT, Manning DR, Lanoce V, Molinoff PB.

Circ Res. 1991 Dec;69(6):1546-56.

PMID:
1659503
48.

Developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines.

Williams K, Hanna JL, Molinoff PB.

Mol Pharmacol. 1991 Nov;40(5):774-82.

PMID:
1682796
49.
50.

Desensitization and down-regulation of 5-HT2 receptors in P11 cells.

Ivins KJ, Molinoff PB.

J Pharmacol Exp Ther. 1991 Oct;259(1):423-9.

PMID:
1656028

Supplemental Content

Loading ...
Support Center